Universe Pharmaceuticals (UPC) EPS (Weighted Average and Diluted): 2020-2024
Historic EPS (Weighted Average and Diluted) for Universe Pharmaceuticals (UPC) over the last 5 years, with Sep 2024 value amounting to -$626.96.
- Universe Pharmaceuticals' EPS (Weighted Average and Diluted) fell 29.75% to $49.4 million in Q1 2024 from the same period last year, while for Mar 2024 it was $232.6 million, marking a year-over-year decrease of 14.29%. This contributed to the annual value of -$626.96 for FY2024, which is 42.44% up from last year.
- Per Universe Pharmaceuticals' latest filing, its EPS (Weighted Average and Diluted) stood at -$626.96 for FY2024, which was up 42.44% from -$1,089 recorded in FY2023.
- In the past 5 years, Universe Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $70.1 million during FY2021, and its lowest value of -$1,309 during FY2022.
- For the 3-year period, Universe Pharmaceuticals' EPS (Weighted Average and Diluted) averaged around -$1,008, with its median value being -$1,089 (2023).
- In the last 5 years, Universe Pharmaceuticals' EPS (Weighted Average and Diluted) surged by 143.52% in 2021 and then slumped by 100.00% in 2022.
- Yearly analysis of 5 years shows Universe Pharmaceuticals' EPS (Weighted Average and Diluted) stood at $28.8 million in 2020, then skyrocketed by 143.52% to $70.1 million in 2021, then tumbled by 100.00% to -$1,309 in 2022, then climbed by 16.80% to -$1,089 in 2023, then soared by 42.44% to -$626.96 in 2024.